|
1
|
Fujiwara K, Mochida S, Matsui A, Nakayama
N, Nagoshi S and Toda G; Intractable Liver Diseases Study Group of
Japan, : Fulminant hepatitis and late onset hepatic failure in
Japan. Hepatol Res. 38:646–657. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Starzl TE, Iwatsuki S, Van Thiel DH,
Gartner JC, Zitelli BJ, Malatack JJ, Schade RR, Shaw BW Jr, Hakala
TR, Rosenthal JT and Porter KA: Evolution of liver transplantation.
Hepatology. 2:614–636. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Polson J and Lee WM; American Association
for the Study of Liver Disease, : AASLD position paper: The
management of acute liver failure. Hepatology. 41:1179–1197. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mochida S and Fujiwara K: Symposium on
clinical aspects in hepatitis virus infection. 2. Recent advances
in acute and fulminant hepatitis in Japan. Intern Med. 40:175–177.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vollmar B, Glasz J, Leiderer R, Post S and
Menger MD: Hepatic microcirculatory perfusion failure is a
determinant of liver dysfunction in warm ischemia-reperfusion. Am J
Pathol. 145:1421–1431. 1994.PubMed/NCBI
|
|
6
|
Hillenbrand P, Parbhoo SP, Jedrychowski A
and Sherlock S: Significance of intravascular coagulation and
fibrinolysis in acute hepatic failure. Gut. 15:83–88. 1974.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kotoh K, Kato M, Kohjima M, Tanaka M,
Miyazaki M, Nakamura K, Enjoji M, Nakamuta M and Takayanagi R:
Lactate dehydrogenase production in hepatocytes is increased at an
early stage of acute liver failure. Exp Ther Med. 2:195–199. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hirata K, Ogata I, Ohta Y and Fujiwara K:
Hepatic sinusoidal cell destruction in the development of
intravascular coagulation in acute liver failure of rats. J Pathol.
158:157–165. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mochida S, Arai M, Ohno A, Yamanobe F,
Ishikawa K, Matsui A, Maruyama I, Kato H and Fujiwara K: Deranged
blood coagulation equilibrium as a factor of massive liver necrosis
following endotoxin administration in partially hepatectomized
rats. Hepatology. 29:1532–1540. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Miyazaki M, Kato M, Tanaka K, Tanaka M,
Takao S, Kohjima M, Enjoji M, Nakamuta M, Kotoh K and Takayanagi R:
Contrast-enhanced ultrasonography using Sonazoid to evaluate
changes in hepatic hemodynamics in acute liver injury. J
Gastroenterol Hepatol. 26:1749–1756. 2100. View Article : Google Scholar
|
|
11
|
Miyazaki M, Kato M, Tanaka K, Tanaka M,
Takao S, Kohjima M, Ito T, Enjoji M, Nakamuta M, Kotoh K and
Takayanagi R: Antithrombin III injection via the portal vein
suppresses liver damage. World J Gastroenterol. 18:1884–1891. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fujiwara K, Okita K, Akamatsu K, Abe H,
Tameda Y, Sakai T, Inoue N, Kanai K, Aoki N and Oka H: Antithrombin
III concentrate in the treatment of fulminant hepatic failure.
Gastroenterol Jpn. 23:423–427. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Graham GG, Scott KF and Day RO:
Tolerability of paracetamol. Drug Saf. 28:227–240. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li C and Martin BC: Trends in emergency
department visits attributable to acetaminophen overdoses in the
United States: 1993–2007. Pharmacoepidemiol Drug Saf. 20:810–818.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jaeschke H and McGill MR: Cytochrome
P450-derived versus mitochondrial oxidant stress in acetaminophen
hepatotoxicity. Toxicol Lett. 235:216–217. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Han D, Dara L, Win S, Than TA, Yuan L,
Abbasi SQ, Liu ZX and Kaplowitz N: Regulation of drug-induced liver
injury by signal transduction pathways: Critical role of
mitochondria. Trends Pharmacol Sci. 34:243–253. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
James LP, McCullough SS, Lamps LW and
Hinson JA: Effect of N-acetylcysteine on acetaminophen toxicity in
mice: Relationship to reactive nitrogen and cytokine formation.
Toxicol Sci. 75:458–467. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Smilkstein MJ, Knapp GL, Kulig KW and
Rumack BH: Efficacy of oral N-acetylcysteine in the treatment of
acetaminophen overdose. Analysis of the national multicenter study
(1976 to 1985). N Engl J Med. 319:1557–1562. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Koch DG, Speiser JL, Durkalski V, Fontana
RJ, Davern T, McGuire B, Stravitz RT, Larson AM, Liou I, Fix O, et
al: The natural history of severe acute liver injury. Am J
Gastroenterol. 112:1389–1396. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Michael Brown J, Ball JG, Wright MS, Van
Meter S and Valentovic MA: Novel protective mechanisms for
S-adenosyl-L-methionine against acetaminophen hepatotoxicity:
Improvement of key antioxidant enzymatic function. Toxicol Lett.
212:320–328. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
James LP, Wells E, Beard RH and Farrar HC:
Predictors of outcome after acetaminophen poisoning in children and
adolescents. J Pediatr. 140:522–526. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ganey PE, Luyendyk JP, Newport SW, Eagle
TM, Maddox JF, Mackman N and Roth RA: Role of the coagulation
system in acetaminophen-induced hepatotoxicity in mice. Hepatology.
46:1177–1186. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Esmon CT: The interactions between
inflammation and coagulation. Br J Haematol. 131:417–430. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ikezoe T: Thrombomodulin/activated protein
C system in septic disseminated intravascular coagulation. J
Intensive Care. 3:12015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Du K, Ramachandran A and Jaeschke H:
Oxidative stress during acetaminophen hepatotoxicity: Sources,
pathophysiological role and therapeutic potential. Redox Biol.
10:148–156. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen R, Hou W, Zhang Q, Kang R, Fan XG and
Tang D: Emerging role of high-mobility group box 1 (HMGB1) in liver
diseases. Mol Med. 19:357–366. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Okamoto T, Tanigami H, Suzuki K and
Shimaoka M: Thrombomodulin: A bifunctional modulator of
inflammation and coagulation in sepsis. Crit Care Res Pract.
2012:6145452012.PubMed/NCBI
|
|
28
|
Li YH, Kuo CH, Shi GY and Wu HL: The role
of thrombomodulin lectin-like domain in inflammation. J Biomed Sci.
19:342012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ikezoe T: Pathogenesis of disseminated
intravascular coagulation in patients with acute promyelocytic
leukemia, and its treatment using recombinant human soluble
thrombomodulin. Int J Hematol. 100:27–37. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Eguchi Y, Gando S, Ishikura H, Saitoh D,
Mimuro J, Takahashi H, Kitajima I, Tsuji H, Matsushita T, Tsujita
R, et al: Post-marketing surveillance data of thrombomodulin alfa:
Sub-analysis in patients with sepsis-induced disseminated
intravascular coagulation. J Intensive Care. 2:302014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Osumi W, Jin D, Imai Y, Tashiro K, Li ZL,
Otsuki Y, Maemura K, Komeda K, Hirokawa F, Hayashi M, et al:
Recombinant human soluble thrombomodulin improved
lipopolysaccharide/d-galactosamine-induced acute liver failure in
mice. J Pharmacol Sci. 129:233–239. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hagiwara S, Iwasaka H, Matsumoto S,
Hasegawa A, Yasuda N and Noguchi T: In vivo and in vitro effects of
the anticoagulant, thrombomodulin, on the inflammatory response in
rodent models. Shock. 33:282–288. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nakamura K, Hatano E, Miyagawa-Hayashino
A, Okuno M, Koyama Y, Narita M, Seo S, Taura K and Uemoto S:
Soluble thrombomodulin attenuates sinusoidal obstruction syndrome
in rat through suppression of high mobility group box 1. Liver Int.
34:1473–1487. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kawasaki T, Okamoto K, Kawasaki C and Sata
T: Thrombomodulin improved liver injury, coagulopathy, and
mortality in an experimental heatstroke model in mice. Anesth
Analg. 118:956–963. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Soto-Montenegro ML, Vicente-Rodríguez M,
Pérez-García C, Gramage E, Desco M and Herradón G: Functional
neuroimaging of amphetamine-induced striatal neurotoxicity in the
pleiotrophin knockout mouse model. Neurosci Lett. 591:132–137.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mortensen MB, Nilsson L, Larsen TG,
Espeseth E, Bek M, Bjorklund MM, Hagensen MK, Wolff A, Gunnersen S,
Füchtbauer EM, et al: Prior renovascular hypertension does not
predispose to atherosclerosis in mice. Atherosclerosis.
249:157–163. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zaman MB, Hoti E, Qasim A, Maguire D,
McCormick PA, Hegarty JE, Geoghegan JG and Traynor O: MELD score as
a prognostic model for listing acute liver failure patients for
liver transplantation. Transplant Proc. 38:2097–2098. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mahrous Abdel Basset Ibrahim, Farooq Ahmed
Wani and Shaik Rahiman: Hepatoprotective effect of olive oil and
camel milk on acetaminophen-induced liver toxicity in mice. Int J
Med Sci Public Health. 6:186–194. 2017. View Article : Google Scholar
|
|
40
|
Saini SP, Zhang B, Niu Y, Jiang M, Gao J,
Zhai Y, Hoon Lee J, Uppal H, Tian H, Tortorici MA, et al:
Activation of liver X receptor increases acetaminophen clearance
and prevents its toxicity in mice. Hepatology. 54:2208–2217.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lisman T and Porte RJ: Rebalanced
hemostasis in patients with liver disease: Evidence and clinical
consequences. Blood. 116:878–185. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Choi DY, Ban JO, Kim SC and Hong JT: CCR5
knockout mice with C57BL6 background are resistant to
acetaminophen-mediated hepatotoxicity due to decreased macrophages
migration into the liver. Arch Toxicol. 89:211–220. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Krenkel O, Mossanen JC and Tacke F: Immune
mechanisms in acetaminophen-induced acute liver failure.
Hepatobiliary Surg Nutr. 3:331–343. 2014.PubMed/NCBI
|
|
44
|
Williams CD, Farhood A and Jaeschke H:
Role of caspase-1 and interleukin-1beta in acetaminophen-induced
hepatic inflammation and liver injury. Toxicol Appl Pharmacol.
247:169–178. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Maddox JF, Amuzie CJ, Li M, Newport SW,
Sparkenbaugh E, Cuff CF, Pestka JJ, Cantor GH, Roth RA and Ganey
PE: Bacterial- and viral-induced inflammation increases sensitivity
to acetaminophen hepatotoxicity. J Toxicol Environ Health A.
73:58–73. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cassidy WM and Reynolds TB: Serum lactic
dehydrogenase in the differential diagnosis of acute hepatocellular
injury. J Clin Gastroenterol. 19:118–121. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Boess F, Bopst M, Althaus R, Polsky S,
Cohen SD, Eugster HP and Boelsterli UA: Acetaminophen
hepatotoxicity in tumor necrosis factor/lymphotoxin-alpha gene
knockout mice. Hepatology. 27:1021–1029. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kopec AK and Luyendyk JP: Role of fibrin
(ogen) in progression of liver disease: Guilt by association? Semin
Thromb Hemost. 42:397–407. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Weerasinghe SV, Moons DS, Altshuler PJ,
Shah YM and Omary MB: Fibrinogen-γ proteolysis and solubility
dynamics during apoptotic mouse liver injury: Heparin prevents and
treats liver damage. Hepatology. 53:1323–1332. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nagato M, Okamoto K, Abe Y, Higure A and
Yamaguchi K: Recombinant human soluble thrombomodulin decreases the
plasma high-mobility group box-1 protein levels, whereas improving
the acute liver injury and survival rates in experimental
endotoxemia. Crit Care Med. 37:2181–2186. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Fujiwara K, Ogata I, Ohta Y, Hirata K, Oka
Y, Yamada S, Sato Y, Masaki N and Oka H: Intravascular coagulation
in acute liver failure in rats and its treatment with antithrombin
III. Gut. 29:1103–1108. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Chiu H, Brittingham JA and Laskin DL:
Differential induction of heme oxygenase-1 in macrophages and
hepatocytes during acetaminophen-induced hepatotoxicity in the rat:
Effects of hemin and biliverdin. Toxicol Appl Pharmacol.
181:106–115. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
van der Poll T, Büller HR, ten Cate H,
Wortel CH, Bauer KA, van Deventer SJ, Hack CE, Sauerwein HP,
Rosenberg RD and ten Cate JW: Activation of coagulation after
administration of tumor necrosis factor to normal subjects. N Engl
J Med. 322:1622–1627. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Sawdey MS and Loskutoff DJ: Regulation of
murine type 1 plasminogen activator inhibitor gene expression in
vivo. J Clin Investig. 88:1346–1353. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Li W, Chen W, Xie M, Huang H, Su H, Han H,
Zhang D, Zhang Y, Yang X and Xu W: Fasudil inhibits tissue factor
and plasminogen activator inhibitor-1 secretion by peripheral blood
mononuclear cells in CAPD patients. Ren Fail. 38:1359–1363. 2016.
View Article : Google Scholar : PubMed/NCBI
|
